IP Library › Granted Patent US 12,246,181
Granted Patent B2
US 12,246,181 · App. 17/653,959 · Granted Mar 11, 2025

Dual chamber pacing

Inventors: Matthew D. Bonner (Plymouth, MN); Kathryn Hilpisch (Cottage Grove, MN); Kaileigh E. Rock (Saint Paul, MN); Jean M. Carver (Blaine, MN)
Assignee: Medtronic, Inc.
A61N1/3684A61N1/0573
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,246,181
App. No.
17/653,959
Filed
Mar 8, 2022
Granted
Mar 11, 2025
Kind
B2
Art Unit
3792
USPC
607/9
Abstract

A medical system includes an implantable medical device that carries a first electrode on a distal end of the implantable medical device and a return electrode. The implantable medical device is configured to be positioned within a heart. The implantable medical device further includes a leadlet including a proximal end and a distal end. The proximal end is attached to the implantable medical device, and the distal end is configured to penetrate tissue of the heart. The leadlet carries a second electrode, and a body of the leadlet between the proximal end and the distal end is configured to flex when the distal end is implanted in the tissue of the heart. The implantable medical device further includes a fixation device attached to the implantable medical device. The fixation device is configured to affix the distal end of the implantable medical device to the heart.

Claims (34)

1. A medical system comprising:

an implantable medical device that carries a first electrode on a distal end of the implantable medical device and a return electrode, wherein the implantable medical device is configured to be positioned within a heart;

a leadlet including a proximal end and a distal end, wherein the proximal end is attached to the implantable medical device, wherein the distal end is configured to penetrate tissue of the heart, wherein the leadlet carries a second electrode, and wherein a body of the leadlet between the proximal end and the distal end is configured to flex when the distal end is implanted in the tissue of the heart,

wherein the leadlet includes a bearing structure configured to receive an elongate member, and wherein the distal end of the leadlet is configured to move in a distal direction when the bearing structure receives the elongate member and a distal force is exerted on the elongate member; and

a fixation device attached to the implantable medical device, wherein the fixation device is configured to affix the implantable medical device to the heart.

2. The medical system of claim 1 , wherein the leadlet is configured to flex to define a substantially curvilinear shape when the fixation device is affixed to the heart and the distal end is implanted in the tissue of the heart.

3. The medical system of claim 1 , wherein the tissue of the heart is ventricular tissue, and wherein the first electrode is configured to provide stimulation to surface tissue in an atrium of the heart when the fixation device affixes the distal end of the implantable medical device to the heart.

4. The medical system of claim 1 , wherein the first electrode and the second electrode are electrically connected to circuitry within the implantable medical device, wherein the circuitry is configured to deliver stimulation signals to the heart using at least one of the first electrode or the second electrode.

5. The medical system of claim 1 , wherein the first electrode and the second electrode are electrically connected to circuitry within the implantable medical device, wherein the circuitry is configured to sense signals from the heart using at least one of the first electrode or the second electrode.

6. The medical system of claim 1 , further comprising a fixation structure supported by the leadlet, wherein the fixation structure is configured to resist motion of the second electrode in a proximal direction when the distal end is implanted in the tissues of the heart.

7. The medical system of claim 1 , wherein the leadlet is configured to exhibit a first stiffness when the bearing structure receives the elongate member and a second stiffness when the elongate member is displaced from the bearing structure, wherein the first stiffness is greater than the second stiffness.

8. The medical system of claim 1 , wherein the bearing structure defines a lumen configured to receive the elongate member.

9. The medical system of claim 1 , wherein the implantable medical device is configured to position in an atrium of the heart when fixation device affixes the distal end of the implantable medical device to the heart and the distal end of the leadlet implants in the tissue of the heart.

10. The medical system of claim 1 , wherein the leadlet carries the second electrode at the distal end of the leadlet.

11. The medical system of claim 1 , wherein the fixation device is configured to resist motion of the implantable medical device in a proximal direction when fixation device affixes the distal end of the implantable medical device to the heart.

12. The medical system of claim 1 , wherein the implantable medical device comprises a housing, wherein the housing supports the return electrode, and wherein the implantable medical device carries the first electrode on a distal end of the housing.

13. The medical system of claim 1 , wherein the leadlet comprises a tip configured to penetrate the tissue to form a puncture sized to enable the leadlet to be inserted therethrough.

14. The medical system of claim 1 , further comprising a delivery catheter defining a catheter lumen, wherein the delivery catheter defines a lumen opening to the catheter lumen at a distal end of the delivery catheter, and wherein the catheter lumen and the lumen opening are sized to allow the implantable medical device, the leadlet, and the fixation device to translate through the catheter lumen and through the lumen opening.

15. A medical system comprising:

an implantable medical device including a housing, wherein the housing carries a first electrode on a distal end of the housing, and wherein the housing carries one or more return electrodes, wherein the housing is configured to be positioned within a heart;

a leadlet including a proximal end and a distal end, wherein the proximal end is attached to the housing, wherein the distal end is configured to penetrate tissue of the heart, wherein the leadlet carries a second electrode, and wherein a body of the leadlet between the proximal end and the distal end is configured to flex when the distal end is implanted in the tissue of the heart,

wherein the leadlet includes a bearing structure defining a lumen configured to receive an elongate member, and wherein the distal end of the leadlet is configured to move in a distal direction when the lumen receives the elongate member and a distal force is exerted on the elongate member;

circuitry supported by the housing, wherein the circuitry is configured to deliver stimulation signals to the heart using the one or more return electrodes and at least one of the first electrode or the second electrode; and

a fixation device attached to the implantable medical device, wherein the fixation device is configured to affix the distal end of the implantable medical device to the heart.

16. The medical system of claim 15 , further comprising a fixation structure supported by the leadlet, wherein the fixation structure is configured to resist motion of the second electrode in a proximal direction when the distal end is implanted in the tissue of the heart.

17. The medical system of claim 15 ,

wherein the leadlet is configured to exhibit a first stiffness when the bearing structure receives the elongate member and a second stiffness when the elongate member is displaced from the bearing structure, and

wherein the first stiffness is greater than the second stiffness.

18. The medical system of claim 15 , wherein the circuitry is configured to sense signals from the heart using one or more of the first electrode, the second electrode, or the one or more return electrodes.

19. A method comprising:

affixing, using a fixation device, an implantable medical device to a heart, wherein the implantable medical device carries a first electrode and a return electrode, wherein the implantable medical device is configured to be positioned within the heart;

receiving, by a bearing structure of a leadlet, an elongate member, wherein a proximal end of the leadlet is attached to the implantable medical device, and wherein a distal end of the leadlet is configured to move in a distal direction when the bearing structure receives the elongate member and a distal force is exerted on the elongate member; and

penetrating, using the distal end of a leadlet, tissue of the heart, wherein a body of the leadlet between the proximal end and the distal end is configured to flex when the distal end is implanted in the tissue of the heart, and wherein the leadlet carries a second electrode.

20. The method of claim 19 , further comprising delivering, using circuitry within the implantable medical device, stimulation signals to the heart using at least one of the first electrode or the second electrode.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2022
From: CARVER, JEAN M.
To: MEDTRONIC, INC.
Reel/Frame 059381/0057 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2022
From: BONNER, MATTHEW D.; HILPISCH, KATHRYN; ROCK, KAILEIGH E.
To: MEDTRONIC, INC.
Reel/Frame 059197/0643 →
Continuity (2)
Provisional Application 63170051 · Apr 2, 2021
Related Publication 20220314001A1 · Oct 6, 2022
References Cited (109)
US 3814104A · Irnich et al. · 1974 [cited by applicant]
US 3835864A · Rasor et al. · 1974 [cited by applicant]
US 3943936A · Rasor et al. · 1976 [cited by applicant]
US 4103690A · Harris · 1978 [cited by applicant]
US 4142530A · Wittkampf · 1979 [cited by applicant]
US 4256115A · Bilitch · 1981 [cited by applicant]
US 4269198A · Stokes · 1981 [cited by applicant]
US 4280512A · Karr et al. · 1981 [cited by applicant]
US 4858623A · Bradshaw et al. · 1989 [cited by applicant]
US 4936823A · Colvin · 1990 [cited by applicant]
US 5193540A · Schulman et al. · 1993 [cited by applicant]
US 5411535A · Fujii et al. · 1995 [cited by applicant]
US 5487758A · Hoegnelid et al. · 1996 [cited by applicant]
US 5573540A · Yoon · 1996 [cited by applicant]
US 5674259A · Gray · 1997 [cited by applicant]
US 5683447A · Bush et al. · 1997 [cited by applicant]
US 6007558A · Ravenscroft et al. · 1999 [cited by applicant]
US 6151525A · Soykan et al. · 2000 [cited by applicant]
US 6212434B1 · Scheiner · 2001 [cited by applicant]
US 6240322B1 · Peterfeso et al. · 2001 [cited by applicant]
US 6286512B1 · Loeb et al. · 2001 [cited by applicant]
US 6409674B1 · Brockway et al. · 2002 [cited by applicant]
US 6575967B1 · Leveen et al. · 2003 [cited by applicant]
US 6643546B2 · Mathis et al. · 2003 [cited by applicant]
US 6783499B2 · Schwartz · 2004 [cited by applicant]
US 6915149B2 · Ben-Haim · 2005 [cited by applicant]
US 6978178B2 · Sommer et al. · 2005 [cited by applicant]
US 7082335B2 · Klein et al. · 2006 [cited by applicant]
US 7139614B2 · Scheiner et al. · 2006 [cited by applicant]
US 7290743B2 · Nowack · 2007 [cited by applicant]
US 7412289B2 · Malonek et al. · 2008 [cited by applicant]
US 7418298B2 · Shiroff et al. · 2008 [cited by applicant]
US 7813805B1 · Farazi · 2010 [cited by applicant]
US 8353940B2 · Benderev · 2013 [cited by applicant]
US 8781605B2 · Bornzin et al. · 2014 [cited by applicant]
US 9017341B2 · Bornzin et al. · 2015 [cited by applicant]
US 9039594B2 · Annest et al. · 2015 [cited by applicant]
US 9597514B2 · Khairkhahan et al. · 2017 [cited by applicant]
US 9901732B2 · Sommer et al. · 2018 [cited by applicant]
US 10039922B2 · Regnier · 2018 [cited by applicant]
US 10159834B2 · Drake et al. · 2018 [cited by applicant]
US 10406370B1 · Makharinsky · 2019 [cited by applicant]
US 10413720B2 · Nuta et al. · 2019 [cited by applicant]
US 10493284B2 · Ortega et al. · 2019 [cited by applicant]
US 10729902B1 · Makharinsky et al. · 2020 [cited by applicant]
US 10792080B2 · Raina et al. · 2020 [cited by applicant]
US 11331475B2 · Drake et al. · 2022 [cited by applicant]
US 20020103424A1 · Swoyer et al. · 2002 [cited by applicant]
US 20020165589A1 · Imran et al. · 2002 [cited by applicant]
US 20030060866A1 · Schmidt · 2003 [cited by applicant]
US 20030088301A1 · King · 2003 [cited by applicant]
US 20040122456A1 · Saadat et al. · 2004 [cited by applicant]
US 20040147973A1 · Hauser · 2004 [cited by applicant]
US 20040230281A1 · Heil et al. · 2004 [cited by applicant]
US 20060084965A1 · Young · 2006 [cited by applicant]
US 20060085039A1 · Hastings et al. · 2006 [cited by applicant]
US 20060085041A1 · Hastings et al. · 2006 [cited by applicant]
US 20060224224A1 · Muhlenberg et al. · 2006 [cited by applicant]
US 20070179552A1 · Dennis et al. · 2007 [cited by applicant]
US 20090082828A1 · Ostroff · 2009 [cited by applicant]
US 20100145382A1 · Chanduszko · 2010 [cited by applicant]
US 20100318172A1 · Schaefer · 2010 [cited by applicant]
US 20120172892A1 · Grubac et al. · 2012 [cited by applicant]
US 20140039591A1 · Drasler et al. · 2014 [cited by applicant]
US 20140066895A1 · Kipperman · 2014 [cited by applicant]
US 20140107723A1 · Hou et al. · 2014 [cited by applicant]
US 20150039070A1 · Kuhn et al. · 2015 [cited by applicant]
US 20150335894A1 · Bornzin et al. · 2015 [cited by applicant]
US 20170326369A1 · Koop et al. · 2017 [cited by applicant]
US 20180050208A1 · Shuros et al. · 2018 [cited by applicant]
US 20190083779A1 · Yang et al. · 2019 [cited by applicant]
US 20190111265A1 · Zhou · 2019 [cited by applicant]
US 20190111270A1 · Zhou · 2019 [cited by applicant]
US 20190143118A1 · Bullinga · 2019 [cited by applicant]
US 20190192863A1 · Koop et al. · 2019 [cited by applicant]
US 20190209845A1 · Stadler et al. · 2019 [cited by applicant]
US 20190232053A1 · Yang et al. · 2019 [cited by applicant]
US 20190269420A1 · Matusaitis et al. · 2019 [cited by applicant]
US 20190351236A1 · Koop · 2019 [cited by examiner]
US 20190374254A1 · Arevalos et al. · 2019 [cited by applicant]
US 20200229805A1 · Gammie et al. · 2020 [cited by applicant]
US 20200229806A1 · Goldfarb et al. · 2020 [cited by applicant]
US 20200261725A1 · Yang et al. · 2020 [cited by applicant]
US 20200261734A1 · Yang et al. · 2020 [cited by applicant]
US 20200289829A1 · Ghosh · 2020 [cited by applicant]
US 20200306522A1 · Chen et al. · 2020 [cited by applicant]
US 20200306530A1 · Koop et al. · 2020 [cited by applicant]
US 20200353249A1 · Min · 2020 [cited by examiner]
US 20200353265A1 · Ghosh et al. · 2020 [cited by applicant]
US 20200398045A1 · Anderson et al. · 2020 [cited by applicant]
US 20210046306A1 · Grubac et al. · 2021 [cited by applicant]
US 20210187307A1 · Ries et al. · 2021 [cited by applicant]
US 20220387764A1 · Bonner et al. · 2022 [cited by applicant]
US 20230012417A1 · Rock et al. · 2023 [cited by applicant]
WO 2002022202A2 · 2002 [cited by applicant]
WO 2006118865A2 · 2006 [cited by applicant]
WO 2018097826A1 · 2018 [cited by applicant]
WO 2020023406A1 · 2020 [cited by applicant]
WO 2020076833A1 · 2020 [cited by applicant]
WO 2020163031A1 · 2020 [cited by applicant]
Hayes, “Advances in pacing therapy for bradycardia”, International Journal of Cardiology, vol. 32, Elsevier Science Publishers B.V., Apr. 1, 1991, pp. 183-196. [cited by applicant]
Petrie, “Permanent Transvenous Cardiac Pacing”, Clinical Techniques in Small Animal Practice, Elsevier Inc., 2005, pp. 164-172, (Applicant points out, in accordance with MPEP 609.04(a), that the year of publication, 200… [cited by applicant]
U.S. Appl. No. 17/805,450, filed Jun. 3, 2022, naming inventors Matthew D. Bonner et al. [cited by applicant]
Austin et al., “Innovative pacing: Recent advances, emerging technologies, and future directions in cardiac pacing”, Trends in Cardiovascular Medicine, vol. 26, Mayo Clinic Florida, 2016, pp. 452-463, (Applicant points … [cited by applicant]
Haqqani et al., “The Implantable Cardioverter-Defibrillator Lead: Principles, Progress and Promises,” PACE, vol. 32, Oct. 2009, pp. 1336-1353. [cited by applicant]
Mulpuru et al., “Cardiac Pacemakers: Functions, Troubleshooting, and Management”, Journal of the American College of Cardiology, vol. 69, No. 2, Oct. 18, 2016, pp. 189-210. [cited by applicant]
Prosecution History from U.S. Appl. No. 17/191,071, dated Jun. 9, 2022 through Jul. 31, 2023, 34 pp. [cited by applicant]
Tjong et al., “Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator,” JACC: Clinical Electrophysiology, vol. 3, No. 13, Dec. 26, 2017, pp. 1487-1… [cited by applicant]
Tjong et al., “The modular cardiac rhythm management system: the EMPOWER leadless pacemaker and the EMBLEM subcutaneous ICD,” Herzschrittmachertherapie + Elektrophysiologie, vol. 29, Oct. 31, 2018, pp. 355-361. [cited by applicant]